SomnoMed Limited

    Jurisdiction
    Australia
    LEI
    529900NFR8QFOLJGP577
    ISIN
    AU000000SOM1 (SOM.AX)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €105.88M
    Gross margin
    55.8%
    EBIT
    -€4.03M
    EBIT margin
    -3.8%
    Net income
    -€9.30M
    Net margin
    -8.8%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €62.46M -41.0% €1.43M -115.4%
    N/A N/A
    N/A N/A

    Dividends

    No dividend payouts

    Add to watchlist

    Notifications